Skip to content

Clinical observation of Jiedu Yizhi prescription treating cognitive impairment of senile brain small vascular disease

Clinical observation of Jiedu Yizhi prescription treating cognitive impairment of senile brain small vascular disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000065
Enrollment
Unknown
Registered
2025-01-10
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral small vessel disease

Interventions

1:Oral butylphthalein soft capsules
2:Jiedu Yizhi prescription of Chinese medicine treatment+Oral butylphthalein soft capsules

Sponsors

The Third Affiliated Clinical Hospital of Changchun University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 100 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria (1) Patients who met the diagnostic criteria of cognitive impairment of cerebral small vessel disease of western medicine and traditional Chinese medicine MMSE score =26 points. (2) The presence of acute CSVD clinical symptoms including TIA lacunar syndrome or subclinical symptoms and the presence of anatomically relevant responsible lesions on MR DWI showed that the lesion was less than 20mm in the acute phase T1T2 or FLAIR showed that the lesion was 3-15mm in the non-acute phase; Or no clinical symptoms of acute CSVD imaging examination with two or more common imaging features of CSVD: lacunar infarction (number =1) leukoaraiosis (Fazekas grade =2) or other combination of fused lesions including microbleeds (number >1 in depth) enlarged perivascular space (number =10 in basal ganglia); (3) patients in stable condition without other serious clinical complications. (4) the course of disease was within 12 months; (5) those who cooperate with the examination and are willing to be evaluated. (6) can accept traditional Chinese medicine treatment not allergic to traditional Chinese medicine. (7) patients over 60 years old. (8) voluntarily participate in this experimental study.

Exclusion criteria

Exclusion criteria: Exclusion Criteria (1) complicated with important organ dysfunction or other serious physical diseases. (2) patients under 60 years old; (3) those who could not cooperate with the evaluation. (4) those who are allergic to traditional Chinese medicine and do not accept traditional Chinese medicine treatment.

Design outcomes

Primary

MeasureTime frame
Montreal Cognitive Assessment (MoCA);Mini-mental State Examination (MMSE);

Secondary

MeasureTime frame
Barthel index;

Countries

China

Contacts

Public ContactGuangcheng Ji

The Third Affiliated Clinical Hospital of Changchun University of Traditional Chinese Medicine

33452285@qq.com18843164081

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026